MedPath

Clinical and Radiological Outcomes Following Insertion of a Novel Removable Percutaneous Interspinous Process Spacer: an Initial Experience.

Completed
Conditions
Degenerative Lumbar Spinal Stenosis
Neurologic Intermittent Claudication
Interventions
Other: percutaneous removable interspinous process
Registration Number
NCT05203666
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

Purpose To evaluate clinical and radiologic outcome of a series of patients treated with a removable percutaneous interspinous process spacer (IPS) (LobsterProject® Techlamed®) for symptomatic degenerative lumbar spinal stenosis (DLSS).

Methods All patients treated in the two considered Centres with this IPS during 2019 were retrospectively reviewed. Patients with incomplete clinical or radiological documentation were not included. Procedures were performed under deep sedation or general anaesthesia by two interventional radiologists. Patients were clinically evaluated before intervention and at 3-month follow-up with Visual Analog Scale for pain (VAS), Oswestry Disability Index (ODI) and radiologically with MRI or CT scans. Neural foramina were independently measured for each patient on pre- and post-procedural CT scans by two radiologists.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • removable percutaneous IPS treatment
  • attended interventional radiology outpatient consultations for back pain and NIC, refractory to medical treatment
Exclusion Criteria
  • PS positioning included cauda equina syndrome
  • permanent motor deficit,
  • previous spine surgery,
  • spondylolisthesis greater than Meyerding grade I,
  • local or systemic infection and severe osteoarthritis with pronounced osteophytosis or bone bridges

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
degenerative lumbar spinal stenosispercutaneous removable interspinous processAll patients treated in 2019 with a percutaneous removable interspinous process spacer a neurologic intermittent clauditation due to a degenerative lumbar spinal stenosis.
Primary Outcome Measures
NameTimeMethod
Oswestry Disability Index3 Months

Disability level evaluated with Oswestry Disability Index after intervention

Secondary Outcome Measures
NameTimeMethod
Visual Analog Scale for pain3 Months

Pain level from 0 (no pain) to 100 (unbearable pain) after intervention

Variation of foraminal area3 Months

Variation of cross sectional area of neural foramina of the treated level on pre-procedural and post-rocedural CT scan

Trial Locations

Locations (1)

Nice University Hospital

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath